Related Experiment Video
Updated: Feb 21, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
The long non-coding RNA NONHSAT062994 inhibits colorectal cancer by inactivating Akt signaling
Xiao-Shun He1, Ling-Chuan Guo1, Ming-Zhan Du1
1Department of Pathology, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China.
Abstract:
The aberrant expression of long noncoding RNAs (lncRNAs) is implicated in cancer development and progression. However, the clinical significance and mechanism by which NONHSAT062994 regulates colorectal cancer (CRC) is unknown. We here reported that NONHSAT062994 was significantly downregulated in human CRC tissues and cell lines. Moreover, its expression was inversely correlated with tumor size and overall survival (OS) time in CRC patients. In CRC cells, the overexpression and knockdown of NONHSAT062994 inhibited and enhanced CRC cell growth, respectively, in vitro and in vivo. Mechanistically, NONHSAT062994 functioned as a tumor suppressor to inhibit CRC cell growth by inactivating Akt signaling. Notably, the NONHSAT062994 expression status was negatively correlated with the Akt downstream targets c-Myc and Cyclin D1 in clinical CRC samples. The current findings suggest that NONHSAT062994 plays a critical role in the development of CRC by regulating Akt signaling, and identified a candidate prognostic biomarker or potential therapeutic target for CRC patients.
Insights
Long noncoding RNA (lncRNA) NONHSAT062994 acts as a tumor suppressor in colorectal cancer (CRC). Its downregulation promotes CRC growth by activating Akt signaling, suggesting it as a potential biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant long noncoding RNA (lncRNA) expression is linked to cancer development.
- The role of NONHSAT062994 in colorectal cancer (CRC) pathogenesis remains unclear.
Purpose of the Study:
- To investigate the clinical significance and functional mechanism of NONHSAT062994 in CRC.
- To determine if NONHSAT062994 can serve as a prognostic biomarker or therapeutic target for CRC.
Main Methods:
- Quantitative real-time PCR to assess NONHSAT062994 expression in CRC tissues and cell lines.
- In vitro and in vivo assays to evaluate the effect of NONHSAT062994 manipulation on CRC cell growth.
- Western blot analysis to examine Akt signaling pathway activation and downstream targets.
Main Results:
- NONHSAT062994 was significantly downregulated in CRC tissues and cell lines.
- Lower NONHSAT062994 expression correlated with larger tumor size and poorer overall survival in CRC patients.
- NONHSAT062994 overexpression inhibited CRC cell proliferation, while its knockdown enhanced it, both in vitro and in vivo.
- NONHSAT062994 suppressed CRC cell growth by inactivating the Akt signaling pathway.
- NONHSAT062994 expression negatively correlated with Akt downstream targets c-Myc and Cyclin D1 in clinical samples.
Conclusions:
- NONHSAT062994 functions as a tumor suppressor in CRC development by inhibiting the Akt signaling pathway.
- NONHSAT062994 represents a potential prognostic biomarker and therapeutic target for colorectal cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...